RUNX3/SOX9 Expression in Relapsed ER plus Breast Cancer

被引：0
|
作者：
Liu, Hui [1 ]
Liu, Hui [1 ]
机构：
[1] Xuzhou Med Univ, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China
来源：
LABORATORY INVESTIGATION | 2021年 / 101卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
108
引用
收藏
页码：123 / 124
页数：2
相关论文
共 50 条
  • [31] SOX9 Expression in Lymphoid Tissues and Lymphomas
    Parilla, Megan M.
    Dama, Paola
    Smith, Sonali
    Hyjek, Elizabeth
    Venkataraman, Girish
    LABORATORY INVESTIGATION, 2018, 98 : 543 - 543
  • [32] Expression of Protein SOX9 in Biliary Atresia
    Arboleda-Bustan, Jenny E.
    Ribalta, Teresa
    Albert, Asteria
    Cuadras, Daniel
    Martin-Sole, Oriol
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2022, 74 (02): : E21 - E26
  • [33] miR-454 Reduces Sensitivity of ER-Positive Breast Cancer Cells to Tamoxifen by Simultaneously Targeting at RUNX3 and ERα
    Liu, Hui
    Xiang, Chenxi
    Ma, Dongshen
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 197 - 198
  • [34] Sox9 Expression during Fracture Repair
    Shintaku, Yuko
    Murakami, Takashi
    Yanagita, Takeshi
    Kawanabe, Noriaki
    Fukunaga, Tomohiro
    Matsuzaki, Kiyomi
    Uematsu, Setsuko
    Yoshida, Yasuhiro
    Kamioka, Hiroshi
    Takano-Yamamoto, Teruko
    Takada, Kenji
    Yamashiro, Takashi
    CELLS TISSUES ORGANS, 2011, 194 (01) : 38 - 48
  • [35] The Influence of TGF-β3, EGF, and BGN on SOX9 and RUNX2 Expression in Human Chondrogenic Progenitor Cells
    Janssen, Jerome Nicolas
    Batschkus, Sarah
    Schimmel, Stefan
    Bode, Christa
    Schminke, Boris
    Miosge, Nicolai
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2019, 67 (02) : 117 - 127
  • [36] Expression and Therapeutic Potential of SOX9 in Chordoma
    Chen, Hua
    Garbutt, Cassandra C.
    Spentzos, Dimitrios
    Choy, Edwin
    Hornicek, Francis J.
    Duan, Zhenfeng
    CLINICAL CANCER RESEARCH, 2017, 23 (17) : 5176 - 5186
  • [37] Clinicopathological significance and potential drug target of RUNX3 in breast cancer
    Yu, Ying-Ying
    Chen, Chao
    Kong, Fan-fei
    Zhang, Wei
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 2423 - 2430
  • [38] Embryonic transcription factor SOX9 drives breast cancer endocrine resistance
    Jeselsohn, Rinath
    Cornwell, MacIntosh
    Pun, Matthew
    Buchwalter, Gilles
    Mai Nguyen
    Bango, Clyde
    Huang, Ying
    Kuang, Yanan
    Paweletz, Cloud
    Fu, Xiaoyong
    Nardone, Agostina
    De Angelis, Carmine
    Detre, Simone
    Dodson, Andrew
    Mohammed, Hisham
    Carroll, Jason S.
    Bowden, Michaela
    Rao, Prakash
    Long, Henry W.
    Li, Fugen
    Dowsett, Mitchell
    Schiff, Rachel
    Brown, Myles
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (22) : E4482 - E4491
  • [39] The clinicopathological significance of RUNX3 hypermethylation and mRNA expression in human breast cancer, a meta-analysis
    Song, Xiao-yun
    Li, Bo-yan
    Zhou, En-xiang
    Wu, Feng-xia
    ONCOTARGETS AND THERAPY, 2016, 9 : 5339 - 5347
  • [40] TrkB Promotes Breast Cancer Metastasis via Suppression of Runx3 and Keap1 Expression
    Kim, Min Soo
    Lee, Won Sung
    Jin, Wook
    MOLECULES AND CELLS, 2016, 39 (03) : 258 - 265
12345